Medical Research | Tissuepathology.com

Lunit and Discovery Life Sciences Collaborate to Expand AI-Powered Tissue Analysis for Biopharma Research

Erica Goodpaster — Mon, 12 Oct 2026 13:40:49 +0000

Lunit and Discovery Life Sciences: Collaboration expands access to Lunit’s AI-powered pathology platform by combining it with Discovery Life Sciences’ global biospecimen and specialty laboratory capabilities, enabling standardized tissue insights for biomarker research and drug development. SEOUL, South Korea, Oct. 12, 2026 /PRNewswire/ — Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision […]

The post Lunit and Discovery Life Sciences Collaborate to Expand AI-Powered Tissue Analysis for Biopharma Research first appeared on Tissuepathology.com.

Agendia to Showcase New Research on AI-Driven Digital Pathology at ESMO 2026

Erica Goodpaster — Tue, 06 Oct 2026 13:10:30 +0000

Agendia Podium presentation by Co-Founder and Chief Research Officer Laura van ’t Veer introduces an AI-driven approach to MammaPrint Two additional poster presentations from the FLEX Study IRVINE, Calif. & AMSTERDAM–(BUSINESS WIRE)–Agendia, Inc., a leader in precision oncology for breast cancer, announced today that it will present new research during a podium presentation on the […]

The post Agendia to Showcase New Research on AI-Driven Digital Pathology at ESMO 2026 first appeared on Tissuepathology.com.

Kaiser, Duke tapped for ARPA-H’s $62.7M autonomous AI bid, Becker’s Health IT

Erica Goodpaster — Wed, 16 Sep 2026 12:38:59 +0000

Kaiser and Duke via Becker’s Health IT: The Advanced Research Projects Agency for Health has awarded contracts to six teams to build the first FDA-authorized agentic AI system for cardiovascular care. ARPA-H announced the selections Sept. 9 under its Agentic AI-EnableD CardioVascular CAre TransfOrmation, or ADVOCATE, program. The four-year, $62.7 million program will fund up to $33.7 […]

The post Kaiser, Duke tapped for ARPA-H’s $62.7M autonomous AI bid, Becker’s Health IT first appeared on Tissuepathology.com.

Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications

Erica Goodpaster — Thu, 27 Aug 2026 13:04:38 +0000

Tempus’ multimodal foundation model offers diagnostic-grade precision for cancer detection and unlocks broader applications predicting biomarker status and patient prognosis CHICAGO, August 4, 2026 — Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced study results demonstrating that PRISM2, a multimodal slide-level pathology […]

The post Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications first appeared on Tissuepathology.com.

Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule

Erica Goodpaster — Tue, 21 Jul 2026 11:30:50 +0000

Optiscan Imaging pushes Stage 2 of head and neck cancer live-imaging study ahead of schedule, accelerating clinical validation and potential FDA submissions. Optiscan Imaging (ASX: OIL) has begun Stage 2 of its first-in-human head and neck cancer imaging study at St John of God Murdoch Hospital in Perth ahead of schedule. The hospital’s Human Research Ethics […]

The post Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule first appeared on Tissuepathology.com.

Mayo Clinic study shows AI can help clinicians identify brain tumor risks

Erica Goodpaster — Thu, 25 Jun 2026 12:54:00 +0000

ROCHESTER, Minn. — Mayo Clinic researchers and collaborators have shown that an artificial intelligence (AI) tool can analyze routine pathology slides to help clinicians classify meningiomas, the most common primary brain tumor in adults, and better understand a patient’s risk of tumor recurrence. The study, published in The Lancet Digital Health, demonstrates that deep learning models can support the extraction of […]

The post Mayo Clinic study shows AI can help clinicians identify brain tumor risks first appeared on Tissuepathology.com.